TP53 and prostate neoplasm: The observed correlation between IL-6R/JAK/STAT3 and MDM2 mRNA levels in prostate tumors regardless of TP53 status could reflect the fact that Mdm2 also has p53-independent oncogenic effects and is overexpressed in mutant TP53 tumors as well54.